AbbVie Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 14.4T 14.1T 12.2T 13.8T
Cost of revenue 4.8T 4.0T 3.7T 4.0T
Gross profit 9.6T 10.1T 8.5T 9.8T
Operating expense
Research & development 2.1T 1.9T 1.9T 6.2T
Selling general and admin 3.3T 3.0T 3.0T 3.5T
Other operating expenses -21.9B
Operating income 4.2T 5.2T 3.6T 76.8B
Non operating interest income
Income 65.8B 56.7B 66.7B 84.1B
Expense 675.4B 676.3B 639.7B 641.5B
Other income expense -2.9T -3.2T -1.5T -1.6T
Pretax income 652.5B 1.4T 1.5T -2.1T
Tax provision 480.7B 560.2B 340.0B -2.1T
Net income 171.8B 860.0B 1.2T -21.0B
Basic EPS 0.5 0.7 0.0
Diluted EPS 0.5 0.7 0.0
Basic average shares 1.6T 1.6T 1.6T
Diluted average shares 1.6T 1.6T 1.6T
EBITDA 5.7T 4.7T 4.3T 1.9T
Net income from continuing op. 171.8B 860.0B 1.2T -21.0B
Minority interests -1.8B -2.7B -2.7B 913.9M
Preferred stock dividends 9.1B 9.1B 9.1B 9.1B
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 4 hours 48 minutes

04:41
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).